Table 2. Treatment Outcomes (PP).

N = 328	Benzathine penicillin (95% CI)	Azithromycin (95% CI)	Risk difference % (95%CI)
Primary Outcome:
Clinical cure at 3 weeks	96.9%(94.1–99.6)	98.2%(96.2–100)	-1.3(-4.7 to 2.0)
Secondary Outcome:
Serological cure at 6 month	49.1% (41.2–56.9)	57.4% (49.9–64.9)	-8.3 (-19.1 to 2.4)